Process View
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of carbohydrates.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of carbohydrate biosynthetic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| INSR | insulin receptor | 0.959 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.896 | Human | |
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.853 | ||
| ESR1 | estrogen receptor 1 | 0.845 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.607 | Rat | |
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.464 | ||
| PRKAB2 | protein kinase, AMP-activated, beta 2 non-catalytic subunit | 0.393 | ||
| AR | androgen receptor | 0.381 | ||
| PRKAB1 | protein kinase, AMP-activated, beta 1 non-catalytic subunit | 0.373 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.355 | ||
| APP | amyloid beta (A4) precursor protein | 0.316 | ||
| SIRT1 | sirtuin 1 | 0.295 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.214 | Human | |
| PRKAA1 | protein kinase, AMP-activated, alpha 1 catalytic subunit | 0.204 | Yeast | |
| NUMB | numb homolog (Drosophila) | 0.191 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.177 | ||
| EGFR | epidermal growth factor receptor | 0.168 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.166 | ||
| EP300 | E1A binding protein p300 | 0.164 | ||
| MAPT | microtubule-associated protein tau | 0.131 | ||
| RARA | retinoic acid receptor, alpha | 0.127 | Human | |
| IRS1 | insulin receptor substrate 1 | 0.127 | ||
| SH2B1 | SH2B adaptor protein 1 | 0.114 | ||
| GHR | growth hormone receptor | 0.111 | ||
| PPP4R2 | protein phosphatase 4, regulatory subunit 2 | 0.111 | ||
| IRS2 | insulin receptor substrate 2 | 0.108 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.107 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.098 | ||
| RXRA | retinoid X receptor, alpha | 0.098 | ||
| DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.094 | Human | |
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.086 | ||
| HIP1 | huntingtin interacting protein 1 | 0.083 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.078 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.077 | ||
| TRRAP | transformation/transcription domain-associated protein | 0.076 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.076 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.074 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.072 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.072 | Human | |
| PPP1R2 | protein phosphatase 1, regulatory (inhibitor) subunit 2 | 0.072 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.057 | ||
| CREBBP | CREB binding protein | 0.057 | ||
| APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | 0.055 | ||
| NOXA1 | NADPH oxidase activator 1 | 0.052 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.051 | ||
| PRKCA | protein kinase C, alpha | 0.051 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.050 | Mouse | |
| TADA3 | transcriptional adaptor 3 | 0.049 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.049 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.047 | ||
| DCTN1 | dynactin 1 | 0.046 | ||
| DYRK1B | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | 0.042 | Human | |
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.041 | Human | |
| ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 | 0.040 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.039 | ||
| THBS1 | thrombospondin 1 | 0.039 | ||
| NRP1 | neuropilin 1 | 0.038 | ||
| HTT | huntingtin | 0.038 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.036 | ||
| STAT5B | signal transducer and activator of transcription 5B | 0.036 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.035 | ||
| PRKAG1 | protein kinase, AMP-activated, gamma 1 non-catalytic subunit | 0.033 | Yeast | |
| CCDC101 | coiled-coil domain containing 101 | 0.032 | ||
| VEGFA | vascular endothelial growth factor A | 0.031 | Human | |
| NCOA3 | nuclear receptor coactivator 3 | 0.030 | ||
| LZTS2 | leucine zipper, putative tumor suppressor 2 | 0.030 | ||
| TADA2A | transcriptional adaptor 2A | 0.028 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.028 | ||
| DCAF7 | DDB1 and CUL4 associated factor 7 | 0.028 | ||
| PRKCB | protein kinase C, beta | 0.028 | ||
| RAB5A | RAB5A, member RAS oncogene family | 0.027 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.027 | ||
| PRKCD | protein kinase C, delta | 0.027 | Human | |
| SEMA6A | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A | 0.027 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.026 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.026 | ||
| FHL2 | four and a half LIM domains 2 | 0.026 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.025 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.024 | ||
| PRKAG2 | protein kinase, AMP-activated, gamma 2 non-catalytic subunit | 0.024 | Yeast | |
| SMAD3 | SMAD family member 3 | 0.024 | ||
| ACACA | acetyl-CoA carboxylase alpha | 0.024 | ||
| FUNDC2 | FUN14 domain containing 2 | 0.023 | ||
| TOM1L1 | target of myb1 (chicken)-like 1 | 0.023 | ||
| ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.022 | ||
| DYRK2 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 | 0.022 | ||
| MATK | megakaryocyte-associated tyrosine kinase | 0.022 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.021 | ||
| PTPRZ1 | protein tyrosine phosphatase, receptor-type, Z polypeptide 1 | 0.021 | ||
| SNCAIP | synuclein, alpha interacting protein | 0.021 | ||
| ENG | endoglin | 0.020 | ||
| ATXN3 | ataxin 3 | 0.019 | ||
| EPS15 | epidermal growth factor receptor pathway substrate 15 | 0.019 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.019 | ||
| PRKAA2 | protein kinase, AMP-activated, alpha 2 catalytic subunit | 0.019 | Yeast | |
| FOXO3 | forkhead box O3 | 0.019 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.019 | Rat | |
| PGF | placental growth factor | 0.018 | Human | |
| DYRK4 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 | 0.018 | Human | |
| USP22 | ubiquitin specific peptidase 22 | 0.018 | ||
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.018 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.018 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.018 | ||
| PRKCZ | protein kinase C, zeta | 0.018 | Human | |
| SH3RF1 | SH3 domain containing ring finger 1 | 0.017 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.017 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.017 | ||
| MLL | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | 0.017 | ||
| RB1 | retinoblastoma 1 | 0.017 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.017 | ||
| EPM2A | epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) | 0.016 | ||
| HDAC6 | histone deacetylase 6 | 0.016 | ||
| RAB6A | RAB6A, member RAS oncogene family | 0.016 | ||
| CAPRIN2 | caprin family member 2 | 0.016 | ||
| LDLR | low density lipoprotein receptor | 0.016 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.016 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.015 | ||
| SQSTM1 | sequestosome 1 | 0.015 | ||
| CHERP | calcium homeostasis endoplasmic reticulum protein | 0.015 | ||
| FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.015 | ||
| PGR | progesterone receptor | 0.015 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.015 | ||
| TP53 | tumor protein p53 | 0.015 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.015 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.015 | ||
| AGL | amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase | 0.014 | ||
| CDCP1 | CUB domain containing protein 1 | 0.014 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.014 | ||
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.014 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.014 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.014 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.014 | ||
| MYB | v-myb myeloblastosis viral oncogene homolog (avian) | 0.014 | ||
| ESRRG | estrogen-related receptor gamma | 0.014 | ||
| ILK | integrin-linked kinase | 0.014 | ||
| TAF4 | TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa | 0.013 | ||
| CCND1 | cyclin D1 | 0.013 | ||
| SLC35A3 | solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3 | 0.013 | ||
| MUC1 | mucin 1, cell surface associated | 0.013 | ||
| PSEN1 | presenilin 1 | 0.013 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.013 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.013 | ||
| ATG13 | ATG13 autophagy related 13 homolog (S. cerevisiae) | 0.013 | ||
| RPTOR | regulatory associated protein of MTOR, complex 1 | 0.013 | ||
| RNF103 | ring finger protein 103 | 0.013 | ||
| LNX1 | ligand of numb-protein X 1 | 0.012 | ||
| SREBF2 | sterol regulatory element binding transcription factor 2 | 0.012 | ||
| ULK1 | unc-51-like kinase 1 (C. elegans) | 0.012 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.012 | ||
| FNBP1L | formin binding protein 1-like | 0.012 | ||
| RANBP9 | RAN binding protein 9 | 0.012 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.012 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.012 | ||
| TNK2 | tyrosine kinase, non-receptor, 2 | 0.012 | ||
| MAP1LC3A | microtubule-associated protein 1 light chain 3 alpha | 0.012 | ||
| GRB14 | growth factor receptor-bound protein 14 | 0.012 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.012 | Mouse | |
| IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 0.012 | ||
| EPOR | erythropoietin receptor | 0.011 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.011 | ||
| UBR5 | ubiquitin protein ligase E3 component n-recognin 5 | 0.011 | ||
| APPL1 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 | 0.011 | ||
| WWP1 | WW domain containing E3 ubiquitin protein ligase 1 | 0.011 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.011 | ||
| CUX1 | cut-like homeobox 1 | 0.011 | ||
| STC1 | stanniocalcin 1 | 0.011 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.011 | ||
| C16orf53 | chromosome 16 open reading frame 53 | 0.011 | ||
| MAPKAP1 | mitogen-activated protein kinase associated protein 1 | 0.011 | ||
| FKBP8 | FK506 binding protein 8, 38kDa | 0.011 | ||
| ARHGAP5 | Rho GTPase activating protein 5 | 0.011 | ||
| CSDE1 | cold shock domain containing E1, RNA-binding | 0.011 | ||
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.011 | ||
| E2F1 | E2F transcription factor 1 | 0.011 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.011 | ||
| NLK | nemo-like kinase | 0.010 | ||
| NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.010 | Mouse | |
| CREB1 | cAMP responsive element binding protein 1 | 0.010 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.010 | ||
| MBL2 | mannose-binding lectin (protein C) 2, soluble | 0.010 | ||
| TRIM23 | tripartite motif containing 23 | 0.010 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.010 | ||
| BAD | BCL2-associated agonist of cell death | 0.010 | ||
| IGF2R | insulin-like growth factor 2 receptor | 0.010 | ||
| NFATC1 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | 0.010 | ||
| SESN2 | sestrin 2 | 0.010 | Mouse | |
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.010 |